Assessing the Efficacy of Mitoxantrone and Doxorubicin as Frontline Anthracyclines During Induction Therapy of Newly Diagnosed Acute Promyelocytic Leukemia

Background: Therapeutic advances in acute promyelocytic leukemia (APL) have transformed it into today's most curable form of leukemia. However, recommended agents, including arsenic trioxide, idarubicin, or daunorubicin, are not easily available in low-middle-income countries, where outcomes remain...

ver descrição completa

Detalhes bibliográficos

Principais autores:	José C. Jaime-Pérez, Eugenia M. Ramos-Dávila, Jesús D. Meléndez-Flores, Mariana González-Treviño, David Gómez-Almaguer
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2024-01-01
coleção:	Hematology/Oncology and Stem Cell Therapy
Assuntos:	acute promyelocytic leukemia remission induction atra mitoxantrone doxorubicin
Acesso em linha:	https://journals.lww.com/10.56875/2589-0646.1090
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!